Bausch Health Companies (TSE:BHC) Shares Up 0.1% - Here's What Happened

Key Points

• Bausch Health Companies shares experienced a slight increase of 0.1%, with the last traded price at C$7.93.
• Insider transactions have been notable, with Director John Paulson acquiring 1,782,030 shares at an average price of C$8.14, indicating strong insider confidence in the company.
• The company's market cap is C$2.06 billion, but it has a negative price-to-earnings ratio of -11.60, suggesting potential challenges in profitability.

Bausch Health Companies Inc. (TSE:BHC - Get Free Report)'s stock price rose 0.1% on Friday . The stock traded as high as C$8.01 and last traded at C$7.93. Approximately 204,437 shares traded hands during trading, a decline of 43% from the average daily volume of 359,679 shares. The stock had previously closed at C$7.92.

Bausch Health Companies Stock Up 0.1%

The company has a fifty day moving average of C$8.47 and a two-hundred day moving average of C$8.42. The company has a debt-to-equity ratio of -1,831.94, a quick ratio of 0.58 and a current ratio of 1.19. The company has a market cap of C$2.51 billion, a PE ratio of -14.11, a price-to-earnings-growth ratio of 0.21 and a beta of 0.77.

Insider Transactions at Bausch Health Companies

In other news, Director John Paulson acquired 1,782,030 shares of Bausch Health Companies stock in a transaction on Friday, June 13th. The shares were bought at an average cost of C$8.14 per share, for a total transaction of C$14,501,803.73. In the last three months, insiders acquired 3,553,401 shares of company stock worth $27,087,675. 11.28% of the stock is owned by insiders.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.